Advertisement

Allogeneic Bone Marrow Transplantation

  • W. G. Ho
  • D. J. Winston
  • R. E. Champlin
  • S. A. Feig
  • R. P. Gale
Chapter
Part of the Developments in Hematology and Immunology book series (DIHI, volume 10)

Abstract

Transplantation of allogeneic bone marrow is increasingly utlized as a modality of treatment for aplastic anemia and leukemia. Patients with these disorders are usually immunocompetent and are able to reject grafts. It is therefore necessary to immunosuppress these patients in preparation for transplantation from donors other than genetically identical twins.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bortin MM, Gale RP, Rinrai AA. Bone Marrow Transplantation Registry. Allogeneic bone marrow transplantation in 144 patients with severe aplastic anemia. JAMA 1981; 245: 1132–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Gale RP. Clinical trials of bone marrow transplantation in leukemia. In: Gale RP, Fox CF, eds. The biology of bone marrow transplantation. New York Academic Press 1980: 11–28.Google Scholar
  3. 3.
    Sparkes MC, Crist ML, Sparkes RS, Gale RP, Feig SA. Gene markers in human bone marrow transplantation. Vox Sang 1977; 33: 202–5.PubMedCrossRefGoogle Scholar
  4. 4.
    Grebe SC, Streilein JW. Graft versus host reactions: A review. Adv Immunol 1976; 22: 119–221.PubMedCrossRefGoogle Scholar
  5. 5.
    Von Bekkum DW. Immunologic basis of graft versus host disease. In: Gale RP, Fox DF, eds. The biology of bone marrow transplantation. New York Academic Press 1980: 175–94.Google Scholar
  6. 6.
    Glucksberg H, Storb R, Fefer A, et al. Clinical graft versus host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 285–304.CrossRefGoogle Scholar
  7. 7.
    Slavin RE, Santos GW. The graft versus host reaction in man after bone marrow transplantation: Pathology, pathogenesis, clinical features and implication. Clin Immunol Immunopathol 1973; 1: 472–98.PubMedCrossRefGoogle Scholar
  8. 8.
    Powles RL, Clink HM, Spence D. Cyclosporin A to prevent graft versus host disease in man after allogeneic bone marrow transplantation. Lancet 1980;i:327–9.CrossRefGoogle Scholar
  9. 9.
    Weiden PL, Doney K, Storb R, et al. Antihuman thymocyte globulin (ATG) for prophylaxis and treatment of graft versus host disease in recipients of allogeneic marrow grafts. Transplant 1978; 10: 213–6.Google Scholar
  10. 10.
    Tutschka PJ, Beschorner WE, Hess AD, Santos GW. Cyclosporin A to prevent graft versus host disease: A pilot study in 22 patients receiving allogeneic marrow transplants. Blood 1983; 61: 318–25.PubMedGoogle Scholar
  11. 11.
    Granger S, Janossy G, Francis G, Blacklock H, Poulter LW, Hoffbrand AV. Elimination of T-lymphocytes from human bone marrow with monoclonal T antibodies and cytolytic complement. Brit J Haematol 1982; 50: 367–94.CrossRefGoogle Scholar
  12. 12.
    Winston DJ, Bryson YJ, Ho WG, Territo MD, Golde DW, Gale RP. Interstitial pneumonia and cytomegalovirus infection after bone marrow transplantation. In: Gale RP, Fox CF, eds. Biology of bone marrow transplantation. New York Academic Press 1980: 83–5.Google Scholar
  13. 13.
    Winston DJ, Ho WG, Champlin RE, Gale RP. Treatment and prevention of interstitial pneumonia associated with bone marrow transplantation. In: Gale RP, Fox CF, eds. Recent advances in bone marrow transplantation. UCLA Symposia on Molecular and Cellular Biology, vol 7. New York: Alan R Liss Inc, Academic Press 1983: 425–44.Google Scholar
  14. 14.
    Meyers JD, Flournoy N, Thomas ED. Nonbacterial pneumonia after allogeneic marrow transplantation: A review of ten years experience. Rev Infect Dis 1982; 4: 1119–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Kraemer KS, Neiman PE, Reeves WC, Thomas ED. Prophylactic adenine arabinoside following marrow transplantation. Transplant Proc 1978; 141: 555–62.Google Scholar
  16. 16.
    Meyers JD, McGuffin RW, Neiman PE, Singer JW, Thomas ED. Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation. Transplant Proc 1978; 10: 237–40.Google Scholar
  17. 17.
    Saral R, Burns WH, Laskin OL, Santos GW, Lietman PS. Acyclovir prophylaxis of herpes-simplex-virus infections: A randomized double blind controlled trial in bone marrow transplant recipients. N Engl J Med 1981; 305: 63–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Meyers JD, McGuffin RW, Bryson YJ, Cantell K, Thomas ED. Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis 1982; 146: 80–4.PubMedCrossRefGoogle Scholar
  19. 19.
    Wade JC, Hintz M, McGuffin RW, Springmeyer SC, Connor JD, Meyers JD. Treatment of cytomegalovirus pneumonia with high dose acyclovir. Am J Med (suppl) 1982; 73: 249–56.CrossRefGoogle Scholar
  20. 20.
    Winston DJ, Pollard RB, Ho WG, et al. Cytomegalovirus immune plasma in bone marrow transplant recipient. Ann Intern Med 1982; 97: 11–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Meyers JD, Leszczynski J, Zaia JA, et al. Prevention of cytomegalovirus infection by cytomegalovirus immune globulin after marrow transplantation. Ann Inter Med 1983; 98: 442–6.CrossRefGoogle Scholar
  22. 22.
    O’Reilly RJ, Reich L, Gold J, et al. A randomized trial of intravenous hyperimmune globulin for the prevention of cytomegalovirus infections following marrow transplantation: Preliminary results. Transplant Proc 1983; 15: 1405–11.Google Scholar
  23. 23.
    Yeager AS, Grumet FC, Hafleigh EB, Arvin AM, Bradley JS, Prober CG. Prevention of transfusion acquired cytomegalovirus infections in newborn infants. J Pediatr 1981; 98: 281–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Camitta BM, Storb R, Thomas ED. Aplastic anemia: Pathogenesis, diagnosis, treatment and prognosis. N Engl J Med 1982; 306: 645–52.PubMedCrossRefGoogle Scholar
  25. 25.
    Camitta BM, Thomas ED, Nathan DG, et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979; 53: 504–16.PubMedGoogle Scholar
  26. 26.
    Champlin RE, Ho WG, Winston DJ, Feig SA, Gale RP. Antithymocyte globulin treatment for aplastic anemia: A controlled randomized trial and comparison with marrow transplantation. Transplant Proc 1983; 15: 595–8.Google Scholar
  27. 27.
    Storb R, Doney KC, Thomas ED, et al. Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 1982; 59: 236–46.PubMedGoogle Scholar
  28. 28.
    Storb R (for the Seattle Marrow Transplant Team) Current status of marrow transplantation for the treatment of aplastic anemia. In: Gale RP, Fox CF, eds. Biology of bone marrow transplantation. New York: Academic Press 1980: 1–10.Google Scholar
  29. 29.
    Storb R, Thomas ED, Buckner CD, et al. Marrow transplantation for treatment of severe aplastic anemia: Results in 20 “untransfused” patients. Ann Intern Med 1980; 92: 30–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Weiden PL, Storb R, Thomas ED, et al. Preceding transfusion and marrow graft rejection in dogs and man. Transplant Proc 1978; 10: 963–4.Google Scholar
  31. 31.
    Storg R, Hansen JA, Weiden PL, Clift RA, Thomas ED. Pretransplant lymphocytotoxins do not predict bone marrow graft rejection. Transplantation 1978; 26: 423–5.CrossRefGoogle Scholar
  32. 32.
    Gluckman E. Pretransplant lymphocytotoxins and bone marrow graft rejection. Lancet 1978;i:443.CrossRefGoogle Scholar
  33. 33.
    Ramsay NKC, Kim T, Nesbit ME, et al. Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia. Blood 1980; 55: 344–6.PubMedGoogle Scholar
  34. 34.
    Parkman R, Rappeport J, Camitta B, Levey RH, Nathan DG. Successful use of multiagent immunosuppression in the bone marrow transplantation of sensitized patients. Blood 1978; 52: 1163–9.PubMedGoogle Scholar
  35. 35.
    Feig SA, Champlin RE, Arenson E, et al. Improved survival following bone marrow transplantation for aplastic anemia. Brit J Haematol 1983; 54: 509–17.CrossRefGoogle Scholar
  36. 36.
    Thomas ED, Sanders JE, Flournoy N, et al. Marrow transplantation in patients with acute lymphoblastic leukemia in remission. Blood 1979; 56: 468–76.Google Scholar
  37. 37.
    Kanti RR, Holland JF, Glidewell OJ, et al. Treatment of acute myelocytic leukemia: A study by cancer and leukemia Group B. Blood 1981; 58: 1203–12.Google Scholar
  38. 38.
    Weiden PL, Flournoy M, Thomas ED, et al. Antileukemic effect of graft versus host disease in human recipients of allogeneic marrow grafts. N Engl J Med 1979; 300: 1068–73.PubMedCrossRefGoogle Scholar
  39. 39.
    Mclntyre RM, Gale RP. Graft versus leukemia in man. In: Kunewick U, Meredith E, eds. Graft versus leukemia. Florida, CRC Press 1981: 1–10.Google Scholar
  40. 40.
    Koeffler HP, Golde DW. Chronic myelogenous leukemia: New concepts. N Engl J Med 1981;304:1201–9 and 1269–74.Google Scholar
  41. 41.
    Cunningham I, Gee T, Dowling M, et al. Results of treatment of Ph+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol). Blood 1979; 53: 375–95.PubMedGoogle Scholar
  42. 42.
    Canellos GP. The treatment of chronic granulocytic leukemia. Clin Hemato1 1977; 6: 113–28.Google Scholar
  43. 43.
    Fefer A, Cheever MA, Greenberg PD, et al. Treatment of chronic granulocytic leukemia with chemotehrapy and transplantation of marrow from identical twins. N Engl J Med 1982; 306: 63–8.PubMedCrossRefGoogle Scholar
  44. 44.
    McGlave PB, Miller WJ, Hurd DD, Arthur DC, Kim T. Cytogenetic conversion following allogeneic bone marrow transplantation for advanced chronic myelogenous leukemia. Blood 1981; 58: 1050–2.PubMedGoogle Scholar
  45. 45.
    Champlin R, Ho WG, Winston DJ, Feig S, Gale RP. Allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic or accelerated phase. Transplant Proc 1983; 15: 1401–4.Google Scholar
  46. 46.
    Messner HA, Curtis JE, Nieman C. Allogeneic bone marrow transplantation in patients with CML prior to blast crisis. Blood (suppl) 1981; 58: 175A.Google Scholar
  47. 47.
    Doney KC, Buckner CD, Thomas ED, et al. Allogeneic bone marrow transplantation for chronic granulocytic leukemia. Exp Hematol 1981; 9: 966–71.PubMedGoogle Scholar
  48. 48.
    Tura S, Baccarni M, Corbelli G. Staging of chronic myeloid leukemia. Brit J Haematol 1981; 47: 105–19.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1984

Authors and Affiliations

  • W. G. Ho
  • D. J. Winston
  • R. E. Champlin
  • S. A. Feig
  • R. P. Gale

There are no affiliations available

Personalised recommendations